Get started
Work

Abstract GS3-01: Menopausal Hormone Therapy and the Risk of Breast Cancer in Women with a Pathogenic Variant in BRCA1 or BRCA2

Year: 2026
Type: conference-abstract
DOI: 10.1158/1557-3265.sabcs25-gs3-01
Authors: J. Kotsopoulos, M. Seca, G. Jacek, T. Huzarski, P. Møller, R. H. Kim, C. Singer, B. Karlan, A. Aeilts, T. Ramon y Cajal, T. Pal, A. Eisen, L. Bordeleau, W. Foulkes, N. Tung, F. Couch, S. Neuhausen, D. Zakalik, C. Cybulski, O. Olopade, K. Metcalfe, R. Fruscio, P. Sun, J. Lubinski, S. Narod
Institutions: Women's College Hospital, University of Milano-Bicocca, Pomeranian Medical University, University Health Network, Princess Margaret Cancer Centre, Comprehensive Cancer Center Vienna, Medical University of Vienna, University of California, Los Angeles, The Ohio State University Wexner Medical Center, The Ohio State University, Hospital de Sant Pau, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Sunnybrook Health Science Centre, Odette Cancer Centre, Juravinski Cancer Centre, Juravinski Hospital, McGill University, Beth Israel Deaconess Medical Center, Mayo Clinic, City of Hope, Beckman Research Institute, Beaumont Hospital, Royal Oak, University of Chicago, University of Toronto
Language: English
Subfield: Genetics
Open Access status: closed
OpenAlex ID: W7129376016
Cites:
Cited by:
Related to: